Quality and Lab Accreditations
CAP and CLIA-certified laboratory
High-quality pharmacogenomics (PGx) testing is the cornerstone of our success. All samples received by RPRD Diagnostics are processed in our CAP and CLIA-certified, fully HIPAA-compliant, diagnostic laboratory. RPRD maintains a robust proficiency testing program to ensure the high quality and accurate patient testing. We maintain 100% pass rate on proficiency tests.
RPRD Diagnostics CAP# 8221917
Download the RPRD Diagnostics CAP Certificate of Accreditation
RPRD Diagnostics CLIA# 52D2126222
Download the RPRD Diagnostics CLIA Certificate of Accreditation
State Licenses
California Lab ID: CDS 00800867
Download the State of California Clinical Laboratory License
Maryland Medical Laboratory Permit No: 3179
Download the State of Maryland Medical Laboratory Permit
New York PFI: 9577
Download the State of New York Clinical Laboratory Permit
Pennsylvania Clinical Laboratory Permit ID No: 38139
Download the State of Pennsylvania Clinical Laboratory Permit
Rhode Island Clinical Laboratory License No: LCO01413
Download the State of Rhode Island Clinical Laboratory Permit
RPRD Diagnostics NPI Number: 1992286074
Quality Assurance
RPRD is committed to delivering the most accurate test results possible. We’ve built rigorous quality assurance and quality control programs that surpass required diagnostic testing standards.
We continuously review the Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines and scientific literature to ensure our translation and clinical reporting strictly adheres to the most up-to-date clinical practice guidelines and strongest scientific evidence.
RPRD laboratory implements robust policies, procedures and regular auditing to ensure 100% compliance with HIPAA standards. Our information security standards meet or exceed all required implementation specifications.
Assay validation demonstrates >99.9% accuracy/agreement of test results.
Internal quality control system ensures 100% concordance for each run.
Bi-annual comparison of observed allelic frequency and expected frequency based on literature review.